Dextromethorphan in Cough Syrup: The Poor Man’s Psychosis
Authors:
- Bridgette MartinakBMBridgette Martinak
- Ramy A. BolisRBRamy A. Bolis
- Jeffrey Ryne BlackJBJeffrey Ryne Black
- Rachel E. FargasonRFRachel E. Fargason
- Badari BirurBBBadari Birur
- 12 August 2025
- journal article
- case report
- Published by MedWorks Media in Psychopharmacology Bulletin
- Vol. 47 (4) , 47-51
Abstract
Dextromethorphan (3-methoxy-N-methylmorphinan), also known as “DXM” and “the poor man’s PCP,” is a synthetically produced drug that is available in more than 140 over-the-counter cough and cold preparations. Dextromethorphan (DXM) has overtaken codeine as the most widely used cough suppressant due to its availability, efficacy, and safety profile at directed doses. However, DXM is subject to abuse. When consumed at inappropriately high doses (over 1500 mg/day), DXM can induce a state of psychosis characterized by Phencyclidine (PCP)-like psychological symptoms, including delusions, hallucinations, and paranoia. We report a noteworthy case of severe dextromethorphan use disorder with dextromethorphan-induced psychotic disorder in a 40-year-old Caucasian female, whose symptoms remitted only following treatment with a combination of an antipsychotic and mood stabilizer. While some states have begun to limit the quantity of DXM sold or restrict sales to individuals over 18-years of age, there is currently no federal ban or restriction on DXM. Abuse of DXM, a readily available and typically inexpensive agent that is not detected on a standard urine drug screen, may be an under-recognized cause of substance-induced psychosis. It is imperative that clinicians are aware of the potential psychiatric sequelae of recreational DXM use.Keywords
This publication has 13 references indexed in Scilit:
- Dextromethorphan: An update on its utility for neurological and neuropsychiatric disordersPharmacology & Therapeutics, 2016
- From PCP to MXE: a comprehensive review of the non‐medical use of dissociative drugsDrug Testing and Analysis, 2014
- How often do false-positive phencyclidine urine screens occur with use of common medications?Clinical Toxicology, 2013
- Dextromethorphan Abuse Leading to Assault, Suicide, or HomicideJournal of Forensic Sciences, 2012
- Monitoring trends in dextromethorphan abuse using the National Poison Data System: 2000–2010Clinical Toxicology, 2011
- Advisers vote against declaring dextromethorphan a controlled substanceAmerican Journal of Health-System Pharmacy, 2010
- Dextromethorphan psychosis, dependence and physical withdrawalAddiction Biology, 2005
- Adolescent Abuse of DextromethorphanClinical Pediatrics, 2005
- Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptorsNeuropharmacology, 2005
- Dextromethorphan An Overview of Safety IssuesDrug Safety, 1992